These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 30088279
1. Subcutaneous implantable cardioverter defibrillator oversensing and shock delivery due to chest compressions during CPR. Berkowitz EJ, Pleimann BE, Rosenfeld LE. Pacing Clin Electrophysiol; 2018 Dec; 41(12):1687-1690. PubMed ID: 30088279 [Abstract] [Full Text] [Related]
3. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. Theuns DAMJ, Brouwer TF, Jones PW, Allavatam V, Donnelley S, Auricchio A, Knops RE, Burke MC. Heart Rhythm; 2018 Oct; 15(10):1515-1522. PubMed ID: 29758404 [Abstract] [Full Text] [Related]
4. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. Olde Nordkamp LR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB, Neuzil P, Wilde AA, Carter N, Husby M, Lambiase PD, Knops RE. Int J Cardiol; 2015 Sep 15; 195():126-33. PubMed ID: 26026928 [Abstract] [Full Text] [Related]
5. An "inappropriately appropriate" shock in a subcutaneous implantable cardioverter-defibrillator: The importance of the SMART pass algorithm. Rubio Campal JM, Benezet-Mazuecos J, Sánchez-Borque P, Blanco ÁM, Crosa J, Arias MA. J Electrocardiol; 2018 Sep 15; 51(6):941-944. PubMed ID: 30497752 [Abstract] [Full Text] [Related]
6. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. Basu-Ray I, Liu J, Jia X, Gold M, Ellenbogen K, DiNicolantonio J, Komócsi A, Vorobcsuk A, Kim J, Afshar H, Lam W, Mathuria N, Razavi M, Rasekh A, Saeed M. JACC Clin Electrophysiol; 2017 Dec 26; 3(13):1475-1483. PubMed ID: 29759827 [Abstract] [Full Text] [Related]
8. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN, Greenlee RT, Go AS, Magid DJ, Cassidy-Bushrow A, Garcia-Montilla R, Glenn KA, Gurwitz JH, Hammill SC, Hayes J, Kadish A, Reynolds K, Sharma P, Smith DH, Varosy PD, Vidaillet H, Zeng CX, Normand ST, Masoudi FA. J Am Heart Assoc; 2017 Nov 09; 6(11):. PubMed ID: 29122811 [Abstract] [Full Text] [Related]
11. Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks. Miyazaki S, Taniguchi H, Kusa S, Komatsu Y, Ichihara N, Takagi T, Iwasawa J, Kuroi A, Nakamura H, Hachiya H, Hirao K, Iesaka Y. Europace; 2015 Feb 09; 17(2):289-94. PubMed ID: 25061229 [Abstract] [Full Text] [Related]
12. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults. Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Köbe J, Eckardt L. JACC Clin Electrophysiol; 2017 Dec 26; 3(13):1499-1506. PubMed ID: 29759830 [Abstract] [Full Text] [Related]
13. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators. Hakamata T, Otsuki S, Izumi D, Sakaguchi Y, Suzuki N, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Fuse K, Inomata T. Heart Rhythm; 2022 Oct 26; 19(10):1704-1711. PubMed ID: 35688344 [Abstract] [Full Text] [Related]
14. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator. Vollmann D, Lüthje L, Görtler G, Unterberg C. Pacing Clin Electrophysiol; 2002 Oct 26; 25(10):1513-6. PubMed ID: 12418750 [Abstract] [Full Text] [Related]
15. [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients]. Larbig R, Bettin M, Motloch LJ, Fischer A, Bode N, Frommeyer G, Reinke F, Loeher A, Eckardt L, Köbe J. Herzschrittmacherther Elektrophysiol; 2018 Mar 26; 29(1):122-126. PubMed ID: 29435656 [Abstract] [Full Text] [Related]
16. An unusual mechanism causing inappropriate implantable cardioverter defibrillator shocks: transient reduction in R-wave amplitude. Baranchuk A, Ribas S, Divakaramenon S, Morillo CA. Europace; 2007 Aug 26; 9(8):694-6. PubMed ID: 17478463 [Abstract] [Full Text] [Related]
17. Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator. Alasti M, Machado C, Kotschet E, Alison J. Heart Lung Circ; 2019 Apr 26; 28(4):e88-e90. PubMed ID: 30482685 [No Abstract] [Full Text] [Related]
18. The "Pain wave": P‑wave oversensing in subcutaneous ICD. Kattih B, Duncker D, König T, Hohmann S, Oswald H, Veltmann C. Herzschrittmacherther Elektrophysiol; 2016 Jun 26; 27(2):151-3. PubMed ID: 27084342 [Abstract] [Full Text] [Related]
19. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL. J Am Coll Cardiol; 2013 Oct 29; 62(18):1674-1679. PubMed ID: 23810882 [Abstract] [Full Text] [Related]
20. Inappropriate shocks due to air entrapment in patients with subcutaneous implantable cardioverter-defibrillator: A meta-summary of case reports. Iavarone M, Rago A, Nigro G, Golino P, Russo V. Pacing Clin Electrophysiol; 2022 Oct 29; 45(10):1210-1215. PubMed ID: 35983947 [Abstract] [Full Text] [Related] Page: [Next] [New Search]